Our results reveal that knockdown of WNK1 decreases SPARC treatment-induced migration and reverses the transition of the mesenchymal phenotype in non-small cell lung cancer cell lines H1299 and CL1-5 (Figure 3D-3F). The gene discussed is WNK1; the disease is small cell lung carcinoma.